Exchange Surveillance
No active ASM or GSM measures on this stock.
Price band ± 20%
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
Alembic Limited is primarily engaged in production of tinctures and alcohol at Baroda. The Company is also engaged in the manufacturing of active pharmaceutical ingredients for anti-parkinsons, anti-depressants, cephalosporins, macrolides and others,Bulk Pharmaceuticals- Under this the company manufactures bulk drugs that are phosgene based and intermediates.Formulation- they manufacture around 150 products under this segment in therapeutic areas such as anti-infective, cough and cold products to cardiovascular and oral anti-diabetics;Herbal and Nutraceuticals- They manufacture herbal and Nutraceuticals and has created brands like Isovon, Protinules, ALA-100, Diax and many more.Alembic also provides contract research services in area of chemistry, bioequivalence and bioanalytical. They also manufacture products for animal care such as Antibiotics-injections, Analgesics, Antipyretics, antidiarrhoeals, Vitamins-Oral and injectable, Tonics and Nutritional feed supplements..The company also engagged in the business of API, Real Estate.
- Sector
- Real Estate
- Industry
- Real Estate - Development
- HQ
- Vadodra, Gujarat
- Chairman
- Chirayu Amin
- CEO & MD
- Malika Amin
- Registrar
- Link Intime India Pvt. Ltd.
- Exchange
- NSE
- ISIN
- INE426A01027
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of Alembic Ltd today?
Alembic Ltd (ALEMBICLTD) is trading at ₹86.73. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is ALEMBICLTD’s P/E ratio versus the sector?
ALEMBICLTD trades at a P/E of 21.0. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is ALEMBICLTD’s dividend yield?
ALEMBICLTD has a dividend yield of 2.41%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is ALEMBICLTD’s 52-week high and low?
ALEMBICLTD has traded between ₹70.46 and ₹117.72 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of Alembic Ltd?
Alembic Ltd has a market capitalisation of ₹2,561 crore.
▶What is ALEMBICLTD’s return on equity?
ALEMBICLTD reports a return on equity of 14.2%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Real Estate - Development.
▶Who are ALEMBICLTD’s competitors?
The Peers block on this page lists other Real Estate - Development companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is ALEMBICLTD’s promoter holding?
Promoters hold 70.88% of ALEMBICLTD. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include ALEMBICLTD?
Index membership is listed in the Context block on this page, along with the weight ALEMBICLTD carries in each. That weight is what determines how much passive money tracks the stock.
▶Is Alembic Ltd a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from ALEMBICLTD’s own numbers. The judgement is yours.
ALEMBICLTD at a glance
Alembic Ltd operates in the Real Estate - Development industry, part of the Real Estate sector. Alembic Ltd (ALEMBICLTD) last traded at ₹86.73, giving it a market capitalisation of ₹2,561 crore. The 52-week range is ₹70.46 to ₹117.72, and the price is 34% of the way up that range. It trades at a price-to-earnings ratio of 21.0. Promoters hold 70.88% of the company in the latest shareholding filing.
| Market cap | ₹2,561 crore |
|---|---|
| P/E | 21.0 |
| ROE | 14.2% |
| ROCE | 16.9% |